Richard Pzena
Pzena Investment Management
Richard Pzena Adient PLC stake
total: 584
Pzena Investment Management ADNT trades
- Total transactions:
- 16
- New positions:
- 1
- Added:
- 9
- Reduced:
- 6
- Held since:
- 2022 Q3
- Held for:
- 16 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Richard Pzena holds 3,771,026 Adient PLC (ADNT) shares with a market value of roughly $69.31M accounting for 0.20% of the overall portfolio. To date, the estimated cost basis is nearly $24.86 for "buy" trades and estimated average "sell" price is $26.5. Pzena Investment Management first purchased ADNT in 2022 Q3, initially acquiring about 1.10M shares. Since the initial investment in Adient PLC (ADNT), Pzena Investment Management has made 15 more transactions.
When did Richard Pzena buy Adient PLC (ADNT)?
Richard Pzena first invested in Adient PLC (ADNT) in 2022 Q3 at the reported quarter-end price of $27.75 per share.
What's the cost basis of Pzena Investment Management's ADNT stake?
The estimated cost basis for Adient PLC (ADNT) stake is around $24.86 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $24.86
- Weighted AVG sell price:
- $26.50
Richard Pzena's historical trades in Adient PLC
16 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.20%
|
3,771,026
|
$18.38
|
$69,311,458
|
+3.73% (+135,729)
|
+0.01%
|
|
2026 Q1
|
0.24%
|
3,635,297
|
$20.21
|
$73,469,352
|
-1.14% (-41,773)
|
-0%
|
|
2025 Q4
|
0.21%
|
3,677,070
|
$19.17
|
$70,489,432
|
-0.34% (-12,610)
|
-0%
|
|
2025 Q3
|
0.29%
|
3,689,680
|
$24.08
|
$88,847,494
|
-11.61% (-484,813)
|
-0.04%
|
|
2025 Q2
|
0.26%
|
4,174,493
|
$19.46
|
$81,235,634
|
+7.00% (+272,920)
|
+0.02%
|
|
2025 Q1
|
0.18%
|
3,901,573
|
$12.86
|
$50,174,229
|
+7.50% (+272,121)
|
+0.01%
|
|
2024 Q4
|
0.21%
|
3,629,452
|
$17.23
|
$62,535,458
|
+28.45% (+803,961)
|
+0.05%
|
|
2024 Q3
|
0.21%
|
2,825,491
|
$22.57
|
$63,771,332
|
+45.02% (+877,142)
|
+0.06%
|
|
2024 Q2
|
0.17%
|
1,948,349
|
$24.71
|
$48,143,704
|
-1.55% (-30,612)
|
-0%
|
|
2024 Q1
|
0.22%
|
1,978,961
|
$32.92
|
$65,147,396
|
+8.89% (+161,579)
|
+0.02%
|
|
2023 Q4
|
0.25%
|
$36.36
|
+17.48% (+270,455)
|
|||
|
2023 Q3
|
0.24%
|
$36.70
|
+25.00% (+309,359)
|
|||
|
2023 Q2
|
0.20%
|
$38.32
|
-2.43% (-30,807)
|
|||
|
2023 Q1
|
0.22%
|
$40.96
|
-6.23% (-84,265)
|
|||
|
2022 Q4
|
0.21%
|
$34.69
|
+23.44% (+256,880)
|
|||
|
2022 Q3
|
0.15%
|
$27.75
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.